7FAY
Crystal structure of SARS-CoV-2 main protease in complex with (R)-1a
Summary for 7FAY
Entry DOI | 10.2210/pdb7fay/pdb |
Descriptor | 3C-like proteinase, (2~{R})-~{N}-[(1~{R})-2-(~{tert}-butylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-~{N}-(4-~{tert}-butylphenyl)-2-oxidanyl-propanamide (3 entities in total) |
Functional Keywords | coronavirus, protease, inhibitor, complex, viral protein., viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) |
Total number of polymer chains | 1 |
Total formula weight | 34237.08 |
Authors | Zeng, R.,Quan, B.X.,Liu, X.L.,Lei, J. (deposition date: 2021-07-08, release date: 2021-07-21, Last modification date: 2023-11-29) |
Primary citation | Quan, B.X.,Shuai, H.,Xia, A.J.,Hou, Y.,Zeng, R.,Liu, X.L.,Lin, G.F.,Qiao, J.X.,Li, W.P.,Wang, F.L.,Wang, K.,Zhou, R.J.,Yuen, T.T.,Chen, M.X.,Yoon, C.,Wu, M.,Zhang, S.Y.,Huang, C.,Wang, Y.F.,Yang, W.,Tian, C.,Li, W.M.,Wei, Y.Q.,Yuen, K.Y.,Chan, J.F.,Lei, J.,Chu, H.,Yang, S. An orally available M pro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron. Nat Microbiol, 7:716-725, 2022 Cited by PubMed: 35477751DOI: 10.1038/s41564-022-01119-7 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report